Peer Education: One Of The Most Underrated Growth Engines In Medtech
In medtech, where adoption of new technologies can be cautious and slow, one powerful driver that often goes overlooked is peer education.
We've all experienced the power of a referral—when someone you trust recommends a book, a treatment or a restaurant, you're far more likely to give it a try. It's not about the pitch. It's about trust.
In medicine, that same dynamic plays out every day. When physicians learn directly from their peers—not sales reps or marketing teams—it carries real weight. A simple, authentic statement like 'I've used this technology, and it really helped my patient' can open doors that no polished demo ever could.
In this article, I will share my experience on why peer education works so well in medtech—and how, when done right, it can become a strategic engine for growth and lasting adoption.
When Trust And Confidence Start With Peer Experience
In healthcare, it makes perfect sense that doctors are cautious with new treatment options. These are decisions that deeply impact the health of patients, and no one takes that lightly.
That's why it's so powerful when a physician can speak to someone who's already using the technology and come out the other side more confident.
I remember clearly the first time I witnessed this in action: the power of one physician describing their experience with my company's cryoablation system to a colleague who was still on the fence. There was no fancy presentation. No pressure. Just a real, honest conversation rooted in clinical experience. That kind of exchange doesn't just build trust; it fosters real confidence.
This is why peer education is more than just a helpful tool, but rather a growth engine that can open doors and create the kind of clinician-led adoption that drives long-term success.
Why Peer Learning Works—Business Value, Not Just Clinical Comfort
Doctors are not interested in being 'sold to' by companies. They want stories from the field from someone who has used the same tool in real-life situations and can speak authentically about patient outcomes.
Peer education works because it bridges the gap between theory and practice and opens a dialogue.
Sharing a lived experience delivers clinical credibility and emotional reassurance. It shortens the path to adoption and lowers the perceived risk of using a new technique.
This is why I see peer-to-peer education as an extension of a company's go-to-market strategy. It's how companies can accelerate confidence, build adoption and, ultimately, support better care.
Peer Learning Models That Work: Intimate, Strategic And High-Touch
In medtech, the most effective peer education models are those that align closely with how physicians prefer to learn: through authentic, practical interactions with their peers.
Rather than relying on sales-driven presentations, smaller hands-on sessions—often led by experienced users or key opinion leaders (KOLs)—create space for authentic clinical discussions. I have found these intimate, peer-led formats consistently foster deeper engagement and greater confidence in adopting new technologies and can do more to shift clinical perspective than months of traditional follow-up.
Tailoring Peer Education To Different Prospect Types
Not every physician learns the same way. Senior clinicians and KOLs often benefit most from direct, strategic dialogue with respected global peers.
I've seen this in action: A leading breast surgeon from the United States and a radiologist from South Africa engaged with a highly regarded breast surgeon who is one of the pioneers of breast cancer cryoablation. The learning went far beyond technical instruction—it became a strategic conversation between peers shaping the future of care.
But other surgeons and breast radiologists who are focused on broadening their treatment offerings may prefer accessible formats like hands-on workshops at events such as those held by the Society of Breast Imaging or the American Society of Breast Surgeons. Sessions like these can offer practical exposure and structured learning through a recognized association of experts in their medical specialty.
Building The Right KOL Relationships—Years In The Making
Building successful KOL relationships relies on trust built over the years. KOLs aren't just spokespeople; they are strategic collaborators, early product co-creators and long-term champions.
The most impactful KOLs often:
• Help shape device usage and treatment protocols.
• Participate in investigator-led studies, case reports and webinars.
• Provide critical feedback that informs product direction.
Throughout my years in the medical device field, I've seen firsthand how building the right relationship with a KOL who is truly passionate about delivering the best patient care can turn them into an exceptional product advocate. Involving physicians in shaping your technology and empowering them to help educate the next generation of doctors is not only rewarding—it can become a powerful driver of your business model.
As another example, an interventional radiologist from CHU de Nimes in France hosted several fellow radiologists from throughout Europe who were looking to expand their knowledge in treating a broader range of tumor types. Through case discussions and observation, he helped his fellow professionals to explore how to apply new tools more widely in their own clinical settings.
Why Trust Is The Real Growth Strategy
Peer education isn't just a marketing gimmick. It is a key business strategy that plays a central role in adoption, especially for high-consideration products that require trust, not just awareness.
When it's done well, peer education delivers more than conversions. It leads to stronger relationships, richer feedback loops and long-term growth. It transforms passive users into active champions.
When people believe in your product and your team, that belief spreads faster than any campaign ever could.
Forbes Business Development Council is an invitation-only community for sales and biz dev executives. Do I qualify?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Heartflow's IPO raises $364M
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Heartflow's initial public offering grossed $364.2 million after the volume and price of the shares sold exceeded the original expectations. The company listed last week and completed the sale of the overallotment on Monday, adding almost $50 million through the sale of additional shares. Heartflow's stock rose in its first two days on public markets, closing at almost $30 on Monday. The company priced its IPO at $19 a share. Dive Insight: Heartflow has developed software for making 3D heart models from coronary computed tomography angiography scans. In a clinical trial, the company linked its lead product, Heartflow FFRCT Analysis, to a 78% improvement in identifying patients in need of revascularization. Heartflow was aiming to sell 12.5 million shares for between $15 and $17 each when it set its IPO range early this month. At the midpoint of the range, the company would have raised $200 million before fees under the original plan. By the time Heartflow finalized the terms last week, the company had agreed to sell 16.7 million shares for $19 each. The changes increased the initial gross IPO amount to $316.7 million. Heartflow raised a further $47.5 million when underwriters took up their options to buy an additional 2.5 million shares in the overallotment. The company estimates net proceeds after fees will be $333.2 million. Heartflow's first two days on public markets provided further evidence of investor enthusiasm. The stock closed at $28.75 on Friday. After peaking and troughing during Monday's session, Heartflow closed up at just below $30. The closing price on Monday was almost 58% higher than the IPO price. The offering extends a recent uptick in IPO activity. Caris Life Sciences priced its IPO at $21 in June, having originally set a range of $16 to $18, and the precision medicine company's stock closed above $30 on Monday. Carlsmed hit the middle of its expected $14 to $16 range, raising more than $100 million to advance its spine platform, but its share price had slipped to $13 by market close on Monday. Recommended Reading Heartflow prices IPO, aiming to net about $180M
Yahoo
17 hours ago
- Yahoo
Izotropic Introduces New Corporate Website & Brand Identity
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - August 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of its new corporate website and refreshed brand identity. The Company's redesigned website, reflects Izotropic's refined corporate positioning and introduces a modern, unique, visual identity that emphasizes its focus on people- patients, clinicians, and stakeholders across the healthcare ecosystem. The site provides an accessible, centralized platform for engaging with Izotropic's story, solutions, and strategy as the Company builds toward commercialization. The updated web presence features streamlined navigation and enriched content, including new presentations, video materials, and messaging that communicates Izotropic's value proposition, clinical direction, and strategic focus. As part of the broader brand system, Izotropic has also introduced a corporate tagline: "Advanced Imaging. Accessible Care.", which appears in materials and corporate communications to communicate the Company's commitment to innovations that can scale across diverse care settings. The Company's flagship product, the IzoView Breast CT Imaging System, carries a new distinct tagline: "Engineered for Today's Challenges and Tomorrow's Care Models.", highlighting its ability to address unmet needs in breast imaging, while capturing its alignment with evolving industry trends driving market expansion. Izotropic invites investors, media, and stakeholders to explore the new site and follow the Company's progress as it works to deliver transformative solutions to the global breast imaging market. About Izotropic: More information about Izotropic Corporation can be found on its website at and by reviewing its profile on SEDAR at Forward-Looking Statements: This document may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions, projections, and expectations of the Company's management, business, and its knowledge of the relevant market and economic environment in which it operates. The Company has tried, where possible, to identify such information and statements by using words such as "anticipate," "believe," "envision," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," "contemplate" and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words. These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company's activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView has not yet been approved or cleared for sale. Contacts: Robert Thast, Interim Chief Executive OfficerTelephone: 1-604-220-5031 or 1-833-IZOCORP ext. 1Email: bthast@ James Gagnon, International CommunicationsTelephone: 1-604-780-7576 or 1-833-IZOCORP ext. 2 General and Corporate InquiriesTelephone: 1-604-825-4778 or 1-833-IZOCORP ext. 3Email: info@ Corporate CommunicationsIBNAustin, OfficeEditor@ To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
18 hours ago
- Forbes
Peer Education: One Of The Most Underrated Growth Engines In Medtech
Tlalit Bussi Tel Tzure is the Vice President of Business Development and Global Marketing for the Medical Device Company, IceCure Medical. In medtech, where adoption of new technologies can be cautious and slow, one powerful driver that often goes overlooked is peer education. We've all experienced the power of a referral—when someone you trust recommends a book, a treatment or a restaurant, you're far more likely to give it a try. It's not about the pitch. It's about trust. In medicine, that same dynamic plays out every day. When physicians learn directly from their peers—not sales reps or marketing teams—it carries real weight. A simple, authentic statement like 'I've used this technology, and it really helped my patient' can open doors that no polished demo ever could. In this article, I will share my experience on why peer education works so well in medtech—and how, when done right, it can become a strategic engine for growth and lasting adoption. When Trust And Confidence Start With Peer Experience In healthcare, it makes perfect sense that doctors are cautious with new treatment options. These are decisions that deeply impact the health of patients, and no one takes that lightly. That's why it's so powerful when a physician can speak to someone who's already using the technology and come out the other side more confident. I remember clearly the first time I witnessed this in action: the power of one physician describing their experience with my company's cryoablation system to a colleague who was still on the fence. There was no fancy presentation. No pressure. Just a real, honest conversation rooted in clinical experience. That kind of exchange doesn't just build trust; it fosters real confidence. This is why peer education is more than just a helpful tool, but rather a growth engine that can open doors and create the kind of clinician-led adoption that drives long-term success. Why Peer Learning Works—Business Value, Not Just Clinical Comfort Doctors are not interested in being 'sold to' by companies. They want stories from the field from someone who has used the same tool in real-life situations and can speak authentically about patient outcomes. Peer education works because it bridges the gap between theory and practice and opens a dialogue. Sharing a lived experience delivers clinical credibility and emotional reassurance. It shortens the path to adoption and lowers the perceived risk of using a new technique. This is why I see peer-to-peer education as an extension of a company's go-to-market strategy. It's how companies can accelerate confidence, build adoption and, ultimately, support better care. Peer Learning Models That Work: Intimate, Strategic And High-Touch In medtech, the most effective peer education models are those that align closely with how physicians prefer to learn: through authentic, practical interactions with their peers. Rather than relying on sales-driven presentations, smaller hands-on sessions—often led by experienced users or key opinion leaders (KOLs)—create space for authentic clinical discussions. I have found these intimate, peer-led formats consistently foster deeper engagement and greater confidence in adopting new technologies and can do more to shift clinical perspective than months of traditional follow-up. Tailoring Peer Education To Different Prospect Types Not every physician learns the same way. Senior clinicians and KOLs often benefit most from direct, strategic dialogue with respected global peers. I've seen this in action: A leading breast surgeon from the United States and a radiologist from South Africa engaged with a highly regarded breast surgeon who is one of the pioneers of breast cancer cryoablation. The learning went far beyond technical instruction—it became a strategic conversation between peers shaping the future of care. But other surgeons and breast radiologists who are focused on broadening their treatment offerings may prefer accessible formats like hands-on workshops at events such as those held by the Society of Breast Imaging or the American Society of Breast Surgeons. Sessions like these can offer practical exposure and structured learning through a recognized association of experts in their medical specialty. Building The Right KOL Relationships—Years In The Making Building successful KOL relationships relies on trust built over the years. KOLs aren't just spokespeople; they are strategic collaborators, early product co-creators and long-term champions. The most impactful KOLs often: • Help shape device usage and treatment protocols. • Participate in investigator-led studies, case reports and webinars. • Provide critical feedback that informs product direction. Throughout my years in the medical device field, I've seen firsthand how building the right relationship with a KOL who is truly passionate about delivering the best patient care can turn them into an exceptional product advocate. Involving physicians in shaping your technology and empowering them to help educate the next generation of doctors is not only rewarding—it can become a powerful driver of your business model. As another example, an interventional radiologist from CHU de Nimes in France hosted several fellow radiologists from throughout Europe who were looking to expand their knowledge in treating a broader range of tumor types. Through case discussions and observation, he helped his fellow professionals to explore how to apply new tools more widely in their own clinical settings. Why Trust Is The Real Growth Strategy Peer education isn't just a marketing gimmick. It is a key business strategy that plays a central role in adoption, especially for high-consideration products that require trust, not just awareness. When it's done well, peer education delivers more than conversions. It leads to stronger relationships, richer feedback loops and long-term growth. It transforms passive users into active champions. When people believe in your product and your team, that belief spreads faster than any campaign ever could. Forbes Business Development Council is an invitation-only community for sales and biz dev executives. Do I qualify?
